Kazia Therapeutics KZIA
NASDAQ KZIA
$7.97 -0.22 (-2.63%)
As of: Oct 22, 2026 · 2:35 PM EDT

Kazia Therapeutics (KZIA) EBIT (2009 - 2013)

Updated

Kazia Therapeutics' EBIT was -$14.38 million in the year ended Jun 30, 2025.

Analysis

Kazia Therapeutics (KZIA) EBIT (2009 - 2013) Analysis & Trends

From the year ended Dec 31, 2009 onward, Kazia Therapeutics has reported EBIT for 17 years.

  • The figure for the year ended Jun 30, 2025 marks the lowest annual EBIT in data going back to the year ended Dec 31, 2009.
  • Per Business Quant data, EBIT in earlier years was -$6.92 million in the year ended Dec 31, 2024, -$5.83 million in the year ended Dec 31, 2023, -$9.54 million in the year ended Dec 31, 2022 and -$10.16 million in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,166.05 Bn 1,134.64 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 647.70 Bn 567.56 Bn 17.30 Bn 6.18 Bn
3 AbbVie 503.26 Bn 476.37 Bn 12.70 Bn 6.43 Bn
4 Merck 366.29 Bn 320.67 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 303.09 Bn 267.08 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 268.96 Bn 242.64 Bn 12.86 Bn 3.16 Bn
7 Amgen 242.14 Bn 197.54 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 194.83 Bn 169.02 Bn 6.22 Bn -10.39 Bn
9 Pfizer 172.37 Bn 119.01 Bn 10.94 Bn 4.27 Bn
10 Kazia Therapeutics 587,129.95 -51.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 -3.92 Mn
Aug 30, 2013 -5.22 Mn
Dec 31, 2012 -8.16 Mn
Dec 31, 2011 14.95 Mn
Dec 31, 2010 16.92 Mn
Dec 31, 2009 2.56 Mn
API Access

Kazia Therapeutics EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=KZIA&period=max&api_key=YOUR_API_KEY